1.
Indian J Med Ethics
;
2014 Apr-June ; 11(2): 71-75
Artigo
em Inglês
| IMSEAR
| ID: sea-153530
RESUMO
In February 2014, the Government of India launched a multi-antiretroviral drug regimen to treat infected women and infants in efforts to reduce parent-to-child transmission (PTCT) of the human immunodeficiency virus (HIV). The announcement has been long awaited because the multidrug regimen can reduce the risk of transmission during childbirth from 30% – 35% to less than 2% with replacement feeding.